Brenntag proves reliable in Poland

Originally published:  20/01/2012

Poland's National Debt Register has awarded Brenntag Polska with a Certificate of Reliability as part of its Reliable Company programme, which seeks to promote business transparency within the country. "The certificate testifies to our strict adherence to the programme's Code of Ethics by pursuing such values as respect for the law, reliability, transparency and responsibility," Brenntag Polska says. "The certificate further confirms Brenntag's commitment to the highest ethical standards in all business activities."

In other news, Brenntag has issued a further statement regarding the ongoing controversy surrounding French breast implant firm Poly Implant Prothèse (PIP). "Brenntag is not aware of the composition of the implant filling called the 'PIP mix' in the media," it says. "It is still unclear to this day to what extent the products delivered by Brenntag have been at all used in the implants. If the silicone oils delivered under the product name of Baysilone are part of the PIP breast implants, they could only have made their way into the implant through intentional criminal and improper use by the French manufacturer Poly Implant Prothèse (PIP) as the oils had been clearly classified as intended for industrial use only."

"Silicone oils can be sold without restrictions – for suppliers there is no legal requirement to monitor subsequent use. Monitoring by suppliers is also unusual because the confidentiality of proprietary formulations and production processes is common practice across many sectors," Brenntag continues. "PIP introduced itself as a broadly positioned healthcare provider that also manufactures and sells various medical devices globally in addition to implants. As far as we are aware, the product range included scab and prosthesis cushions, for instance. As a result, there was no evidence suggesting that the products delivered by Brenntag could be intended for use in the human body."

www.brenntag.com



Share this article via Twitter, LinkedIn or Facebook.